SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Derivatives

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (99)4/17/1999 6:20:00 PM
From: sim1  Read Replies (3) of 555
 
Drug Discovery Technology 1999

August 16-19, 1999 · The Seaport Hotel & World Trade Center · Boston, MA

drugdisc.com

Keynote Presentations

Leroy Hood, M.D., Ph.D., Gates Professor and Chairman, Department of
Molecular Biotechnology, University of Washington (PLUS PHOTO) Title of Presentation: "Lessons from the Human Genome Project: A Revolution in Biology and Medicine of the 21st Century"

Michael Pavia, Ph.D., Chief Technology Development Officer, Millennium
Pharmaceuticals, Inc. (PLUS PHOTO) Title of Presentation: Millennium's
Integrated Technology Platforms for Improving Drug Discovery and
Development"

George Poste, Ph.D., Chief Science and Technology Officer, SmithKline
Beecham Pharmaceuticals (PLUS PHOTO) Title of presentation: "Re-Engineering R&D for the Next Millennium"

Stuart L. Schreiber, Ph.D., Co-Director, Harvard Institute of Chemistry & Cell Biology, Harvard University (PLUS PHOTO) Title of Presentation: "Specificity and Generality in Chemical Genetic Research"

Monday, August 16, 1999
7:30 Morning Pre-Conference Symposium Registration Pre-Conference
Symposia - [optional, choose from list]
8:30-12:00 Toxicity Prediction in Drug Discovery
1:30-5:30 Overcoming Key Bottlenecks in the Drug Discovery Cascade
1:30-5:30 Strategic Alliances and Collaborations in Research
and Pre-Clinical Development
5:30-8:00 Opening Night Networking Reception

Tuesday, August 17, 1999
6:30 Main Conference Registration
8:00-9:30 Keynote Presentations
Stuart L. Schreiber, Ph.D., Harvard University
George Poste, Ph.D., SmithKline Beecham Pharmaceuticals

Conference Tracks - [choose a track]
10:15-12:50 Parallel Sessions
Track 1: Target Discovery and Validation through Genomics
Track 2: Miniaturization and Biochip Technologies
12:50-3:00 Poster/Exhibit Viewing and Lunch in the Exhibit Hall
Technology Workshops - [choose one from each group]
3:00-4:00 Molecular Devices
Pangea Systems
PE Biosystems
4:15-5:15 CCS Packard
Ciphergen
Corning
5:15-7:45 Networking Reception

Wednesday, August 18, 1999

8:10-9:35 Keynote Presentations
Leroy Hood, M.D., Ph.D., University of Washington
Michael Pavia, Ph.D., Millennium Pharmaceuticals, Inc.
10:20-12:25 Track 1: Chemistries and Synthesis Techniques
Track 2: High-Throughput Screening
12:25-2:25 Poster/Exhibit Viewing and Lunch in the Exhibit Hall
2:25-6:00 Track 1: Protein Technologies AND Lead Discovery and
Optimization
Track 2: Bioinformatics AND Integrating Technologies
6:30 New England Clambake

Thursday, August 19, 1999
8:15-12:00 Drug Discovery Case Histories
12:00 Close of Drug Discovery Technology '99
American Chemical Society Short Courses - [optional]
12:10 Registration for American Chemical Society Short Courses
12:30-6:00 American Chemical Society Short Courses

Organic Chemistry of Drug Design and Drug Action

Drug Discovery Using Molecular Biology Techniques to Find Drug Targets

Synthetic Organic Chemistry: Modern Methods and Strategies

Friday, August 20, 1999
8:00-5:00 American Chemical Society Short Courses Continue

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext